KALA Kala Pharmaceuticals Inc

Price (delayed)

$0.56

Market cap

$10.83M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$33.46

Enterprise value

$10.6M

?
Relative Growth: Rel. Growth: 16
Relative Strength: Rel. Strength: 0
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 11

Kala is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye. Kala’s biologics-based investigational therapies utilize Kala’s ...

Highlights
KALA's debt has shrunk by 100% YoY
The EPS has surged by 90% year-on-year and by 66% since the previous quarter
KALA's quick ratio has soared by 136% YoY but it is down by 17% from the previous quarter
Kala Pharmaceuticals's equity has decreased by 16% QoQ

Key stats

What are the main financial stats of KALA

KALA stock price

How has the Kala Pharmaceuticals stock price performed over time
Intraday
-6.51%
1 week
7.36%
1 month
-31.72%
1 year
-99.93%
YTD
-97.99%
QTD
-67.63%

Financial performance

How have Kala Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.82M
Net income
-$10.08M
Gross margin
N/A
Net margin
N/A
Kala Pharmaceuticals's net income has surged by 73% YoY and by 49% QoQ
KALA's operating income is up by 36% YoY and by 26% QoQ

Price vs fundamentals

How does KALA's price correlate with its fundamentals

Growth

What is Kala Pharmaceuticals's growth rate over time

Valuation

What is Kala Pharmaceuticals stock price valuation
P/E
N/A
P/B
1.15
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 90% year-on-year and by 66% since the previous quarter
Kala Pharmaceuticals's equity has decreased by 16% QoQ

Efficiency

How efficient is Kala Pharmaceuticals business performance
The return on equity has surged by 83% since the previous quarter and by 68% year-on-year
The company's return on assets rose by 26% QoQ and by 9% YoY
The ROIC rose by 23% QoQ but it fell by 7% YoY

Dividends

What is KALA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KALA.

Financial health

How did Kala Pharmaceuticals financials performed over time
KALA's quick ratio has soared by 136% YoY but it is down by 17% from the previous quarter
The company's total liabilities has shrunk by 96% YoY
KALA's debt is 100% lower than its equity
KALA's debt has shrunk by 100% YoY
The debt to equity has soared by 100% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.